Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
 
Articles by A.I. Almubarak
Total Records ( 3 ) for A.I. Almubarak
  A.I. Almubarak
  The effects of ephedrine on Arterial Blood Pressure (ABP), heart rate, respiratory rate and some haematology and biochemistry parameters were carried out on six camels in two periods. In the first period, all camels received Intravenous (IV) 0.2 mg kg-1 xylazine while in the second period, same camels received IV 0.2 mg kg-1 ephedrine followed 10 min later by IV 0.2 mg kg-1 ephedrine and 0.2 mg kg-1 xylazine administered at same time. Cardiopulmonary measurements were taken at baseline and were further recorded at 10, 20, 30, 40, 50 and 60 min after treatment in both groups. Mean heart rate, respiratory rate and ABP measurements decreased significantly after xylazine in the first period. Mean heart rate in the second period decreased significantly at all times compared to baseline and to first period while mean ABP measurements were significantly higher at 10, 20, 30 and 40 min compared to first period. There was a significant decrease of Platelet count (PLT), Haemoglobin (HB), Urea Nitrogen (BUN), Albumen (ALB), Alanine aminotransferase (ALT) and Glucose (GLU) in the first period compared to the second period and there was significant increase of Calcium (Ca) and potassium (K+) after treatments in the second period. Ephedrine was safe and effective in improving ABP in xylazine induced hypotension in camels.
  A.I. Almubarak
  The effects of doxapram on respiratory rate, heart rate, Arterial Blood Pressure (ABP) and some haematology and biochemistry parameters were carried out on six camels in two periods. In the first period, all camels received Intravenous (IV) 0.2 mg kg-1 xylazine while in the second period, same camels received IV 0.4 mg kg-1 doxapram, followed 10 min later by IV 0.2 mg kg-1 xylazine. Cardiopulmonary measurements were taken at baseline and were further recorded at 10, 20, 30, 40, 50 and 60 min after treatment in both periods. Mean respiratory rate, heart rate and ABP measurements decreased significantly after xylazine in the first period. Mean respiratory rate in the second period increased significantly at 10 min while systolic ABP increased significantly at 30 min when compared with first period. Mean heart rate decreased significantly at 20 min in the second period when compared with first period. There was a significant differences between the two periods in some measured haematological and biochemical parameters. Doxapram was useful to increase respiratory rate and ABP in xylazine sedated camels. Higher doses of doxapram needed further investigation in camels.
  A.Y. Al-Taher , M.K. Zabady , A.I. Almubarak , M. Ismail and R.O. Ramadan
  This study was conducted to evaluate the analgesic and sedative efficacy of the combination of tramadol-xylazine used in six dromedary camels underwent soft tissue surgeries and premidicated with Intravenous (IV) 0.2 mg kg-1 of xylazine. The combination was induced IV with 2.0 mg kg-1 of tramadol and 0.2 mg kg-1 of xylazine, IV top-up of the combination of the same original doses was injected whenever the analgesia was inadequate or when surgical stimulation provoked movement. A surgically satisfactory analgesia was achieved and maintained in all camels by this combination except in two camels that underwent perineal laceration and castration showing signs of distress and pain as the injection dose was insufficient even after a supplemental dose at the same original dose was administered. Mean time±SD from administration of the combination of tramadol-xylazine until end of operation was 39.5±10.1 min. This study concludes that the combination of tramadol-xyalzine was effective and safe to use in camels and suggests that combination can be improved upon by combining with local analgesic drug to achieve adequate depth of analgesia.
 
 
 
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility